Skip to main content
Healthy Adult Male and Female VolunteersSleepHealthy volunteersHealthmaxxingDrugPhase 1

What this study is

Characterize the safety, tolerability and pharmacokinetics of ORX489 following single and multiple doses.

What's being tested

  • ORX489 Tablets

    Intervention · DRUG

    ORX489 Tablets

  • Placebo Tablets

    Intervention · OTHER

    Placebo Tablets

Study details

Official title
A Safety, Tolerability, Pharmacokinetic, Food Effect, and Proof-of-Concept Study of Single and Multiple Doses of ORX489 in Healthy Adults
Sponsor
Centessa Pharmaceuticals (UK) Limited
Conditions
Healthy Adult Male and Female Volunteers
Enrolling
212 people
Starts
2026-02-25
Est. completion
2027-06-30
Design
Double-blind, randomized, parallel groups, Phase 1
Record
View on ClinicalTrials.gov ↗